New cancer clinical trial: HPPH Photodynamic Therapy for Patients With Esophageal Cancer

Published on: November 29, 2018 at 12:00PM
Condition:   Esophageal Cancer
Interventions:   Drug: HPPH 2.5 mg/m2;   Drug: HPPH 3 mg/m2;   Drug: HPPH 3.5 mg/m2;   Drug: HPPH 4 mg/m2;   Drug: HPPH 5 mg/m2;   Drug: HPPH 6 mg/m2
Sponsor:   Zhejiang Hisun Pharmaceutical Co. Ltd.
Active, not recruiting
https://ift.tt/2FMj4jh